Hikma Pharmaceutical | HIK - Interest Expense On Debt

Stock Price
1,597.00
Daily Change
43.00 2.77%
Monthly
4.58%
Yearly
-30.02%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $20M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
argenx SE USD 993K 133K Sep/2025
AstraZeneca USD 303M 38M Jun/2025
Autolus Therapeutics Ltd USD 10.52M 17.35M Sep/2025
Bayer EUR 762M 267M Sep/2025
Fresenius EUR 81M 5M Sep/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 37M 28M Sep/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 126M 47M Sep/2025
Orion EUR 600K 600K Sep/2025
Recordati EUR 20.69M 3.8M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 78M 30M Jun/2025